ANTISENSE MODULATION OF PTPN12 EXPRESSION

Details for Australian Patent Application No. 2003236510 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors COWSERT, Lex, M.; DOBIE, Kenneth, W.

Pub. Number AU-A-2003236510

PCT Number PCT/US03/18707

PCT Pub. Number WO2003/106712

Priority 10/172,911 17.06.02 US

Filing date 12 June 2003

Wipo publication date 31 December 2003

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 031/07

A01N 043/04 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 10/172,911 17.06.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-A-2003236510

3 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003236511-Metal complexes for use in metathesis

2003236509-Method of treating ischemia reperfusion injury using adenosine receptor antagonists